| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |